Mid ka mid ah waxyaabaha dheeraadka ah ee lagu baranayo nafaqada ee PCOS-ka waa inositol. Sababta wanaagsan: labadaba Myo (MYO) iyo d-Chiro-inositol (DCI) noocyada inositol ayaa lagu muujiyey in ay kor u qaadaan qaar badan oo ka mid ah qaybaha taranka iyo taranka ee PCOS. Faa'idooyinkaas waxaa ka mid ah hagaajinta kolesteroolka , insulin, iyo xajmiga iyo culeyska. Dumarka qaata inositol waxay soo sheegaan jahwareer yar.
Ugu wanaagsan ee dhammaan, MYO waxaa loo muujiyay inay kor u qaaddo bacriminta iyada oo la hagaajinayo tayada ukunta iyo dib u soo celinta caadada iyo si fiican oo loo yareeyo khatarta ugu jirta macaanka uurka.
In kastoo noocyada MYO iyo DCI labadaba faa'iidooyin badan ay u leeyihiin haweenka PCOS, cilmi-baaris cusub ayaa hadda muujisay in ay tahay isku-dhafka labada nooc, oo ah saamiga dabiiciga ah ee jidhka ee muujinaya faa'iidada ugu badan.
Waa maxay Inositol?
Inositol waa xubin ka mid ah B-fitamiinada iyo qayb ka mid ah xuubka unugyada. Inositol waxaa laga helaa cuntooyinka sida miraha, digirta, miro, iyo lowska oo sidoo kale waxaa sameeya jirka. In kasta oo ay jiraan sagaal nooc oo ah inositol, waa MYO iyo DCI kuwaas oo muujiyay faa'iidooyinka ugu wanaagsan ee PCOS. Sababtoo ah waxaa la rumaysan yahay in haweenka haysta PCOS ay leeyihiin cillad ku jirta awoodda jirka ee isticmaalka MYO iyo DCI, oo wax ka geysta caabbinta insulin . MYO iyo DCI waxay u shaqeeyaan farriimo labaad oo riixaya calaamadaha ku lug leh qawaaniinta insulin.
Faa'iidooyinka Myo iyo D-Chiro Inositol Isku dar
MYO iyo DCI waa lakabyo kala duwan oo ka shaqeeya jidhka.
DCI waxaa laga sameeyaa MYO marka loo baahdo . Jirku wuxuu hayaa isugeyn caadi ah MYO si uu u saamaxo DCI 40: 1. Saamaynta MYO-ga ee DCI ee dareeraha quman ayaa ah mid aad u sarreeya- 100: 1. Foolikada leh oocytes tayadiisu sarayso ayaa leh feejignaan badan oo ah MYO.
Is-dheellitirnaanta MYO-ga caadiga ah ee DCI waxay saameyn kartaa tayada ukunta.
Markii DCI keliya la maamulay qiyaasta sare (600-2400mg maalintii) waxaa la ogaaday inay si xun u saameynayso tayada oocyte iyo jawaabta ugxan-la'aanta. Maxaase ka sii badan, qadarka sare ee DCI (iyo isku dheelitir la'aanta saamiga MYO-ga ee DCI), ayaa sii xumaatay tayada oocyte iyo jawaabta ugxan-la'aanta .
MYO ayaa si wanaagsan loo diiwaangeliyey inay ka sareyso DCI sidii loo hagaajin lahaa caabbinta insulin, tayada ukunta iyo yaraynta khatarta diabeteska ee haweenka qaba PCOS. Si kastaba ha noqotee, marka MYO la isku daro DCI marka la eego heerka ugu sarreeya, natiijooyinka ugu wanaagsan ayaa la arkaa.
Daraasad lagu daabacay Jariidada Archives of Gynecology iyo Obstetrics , haweenka haysta PCOS ee ku jira IVF waxaa lagu daaweeyaa isku dhafka MYO iyo DCI ee saamiga jir ahaaneed ee 40: 1 ama 500 mg oo DCI ah oo keliya. Daaweynta isku jirka ah waxay awood u laheyd inay kor u qaaddo oocyt iyo tayada embriyaha, iyo sidoo kale heerka uurka, oo muujinaya in MYO ay door muhiim ah ka ciyaareyso ugxan-haweenka PCOS haweenka iyo faa'iidooyinka MYO iyo DCI ee saamiga ugu wanaagsan.
Daraasad kale oo la daabacay sanadkaan ee Dib u eegista Yurub ee Farsamada iyo Faragelinta Fayo-qabka , haweenka cayilan ee PCOS waxay heleen MYO iyo DCI ama MYO oo keliya 6 bilood. Dhamaadka daaweynta, dhammaystirka wadajirka ah ee MYO iyo DCI wuxuu ahaa mid wax ku ool ah marka la dhimayo xaddiga dheef-shiid kiimikaadka marka la barbar dhigo kooxda MYO.
Qorayaashu waxay soo gabagabeeyeen in "maamulka isku-dhafan ee MI iyo DCI ee saamiga miisaanka faytoommeed (40: 1) waa in loo tixgeliyaa habka ugu horreeya ee PCOS.
Waxyaabaha Laga Baahan Yahay Inositol?
Waxaa lagu talinayaa in haweenka PCOS ay qaataan miisaan isku dhafan oo MYO ah (2-4 garaam) iyo DCI (50-100mg) ee saamiga jireed ee 40: 1.
Guud ahaan, MYO iyo DCI ayaa si fiican u dulqaadan kara, laakiin waxay keeni kartaa sonkorta dhiigga oo hoos u dhacda , gaar ahaan haddii ay qaadato daawooyinka ama daawooyinka kale ee hoos u dhigaya sonkorta dhiigga. Sida had iyo jeer, ka hubi dhakhtarkaaga ka hor intaadan bilaabin inositol.
> Ilo:
> Costantino D, Minozzi G, Minozzi E, Guaraldi C. Saameynta Metaboliga iyo Saamaynta Saameynta Saameynta Myoinositol ee Haweenka leh Polycystic Ovary Syndrome: waa tijaabo laba-ilbiriqsi ah. Falanqaynta Europ Daawada Med Pharmacol 2009; 13 (2): 105-110.
> Faafinta V, Carlomagno G, Rizzo P, Raffone E, Roseff S. Myo-Inositol Aan D-Chiro-Inositol Laga Qaadan Karo Tayada Oocyte ee Hurgumada Wareegta Intracytoplasmic Sperm. Hoos-u-dhac, Xakameyn, Maxkamad Gaabis ah. Falanqaynta Europ Daawada Med Pharmacol 2011; 15 (4): 452-457.
> Le Donne M, Alibrandi A, Giarrusso R, Lo Monaco I, Muraca U. [Diet, Metformin iyo Inositol oo ku jira Dhiigheerka iyo Dumarka Cudurka Dabeecada ah ee Polycystic Ovary Syndrome: Saameyn ku Saabsan Nolosha Dhaqanka]. Minerva Ginecologica. 2012; 64 (1): 23-29.
> Venturella R, Mocciaro R, De Trana E, D'Alessandro P, Morelli M, Zullo F. [Qiimaynta Isbeddelka Qalitaanka Daawada Clinic, Endocrinik iyo Metabolikal ee bukaanada leh PCOS Syndrome oo lagu daaweeyo MYO-Inositol]. Minerva Ginecologica. 2012; 64 (3): 239-243.
> Genazzani AD, Prati A, Santagni S, et al. Jawaabta Insulin ee kala duwan ee Maamulka Cusbitaalka ee Myo-Inositol ee Bukaan-socodka Cudurka Dabeecada ah ee Asaasiga ah. Gynecol Endocrinol. 2012; 28 (12): 969-973.
> Gerli S, Papaleo E, Ferrari A, Di Renzo GC. Iskudhin la'aan, Labo-indho-gudbi Xakameyn-La-kaantaroolo: Saamaynta Myo-Inositol ee Hawsha Oogada iyo Ciladaha Dheef-shiid kiimikaad ee Haweenka La Shaqeeya PCOS. Europ Rev Rev Pharmacol Sci . 2007; 11 (5): 347-354.
> Raffone E, Rizzo P, Benedetto V. Insulin Dareesayaasha Wareegaha Kaliya Iyo Daaweynta R-FSH ee Hoosudhaca Hoosaadka ee Haweenka PCOS. Gynecol Endocrinol. 2010; 26 (4): 275-280.
> Galazis N, Galazi M, Atiomo W. D-Chiro-Inositol iyo Waxyaabaha Muhiimka u ah ee ku jira Xanuunada Polycystic Ovary Syndrome: Dib-u-eegis habaysan. Gynecol Endocrinol . 2011; 27 (4): 256-62
> Papaleo, E., Faa'iido, V., Baillargeon, JP, et al. (2007). Myo-Inositol ee Bukaanka qaba Polycystic Ovary Syndrome: Habka Habka Cusub ee Hoosudhaca Hoosaadka. Endocrinology Gynecological, 23 (12): 700-703.
> D 'Anna R, Di Benedetto V, Rizzo P, iyo al. MYO-Inositol waxay ka hortagtaa Sonkorta Uurka ee Haweenka PCOS. Gynecol Endocrinol. 2012; 28 (6): 440-442.
> Isabella R, Raffone E. Miyuu u Diyaargaroobaa D-Chiro-Inositol? J Ovarian Res. 2012 May 15; 5 (1): 14.
> Dinicola S1, Chiu TT, Furtay V, Carlomagno G, Bizzarri M. Miisaanka Maaroinositol iyo D-Chiro-Inositol Daaweynta Isbitaalka Polycystic Ovary Syndrome. J Clin Pharmacol. 2014 Oct; 54 (10): 1079-92.
> Nordio M, Proietti E. Daaweynta Wadnaha ee Myoinositol iyo D-Chiro-Inositol wuxuu yareynayaa Khatarta Cudurka Metabolic ee PCOS-ga Cusub ee Bukaanka Isbarbardhigaya Xanuun Dhimirka Myoinositol. Eur Rev Med Pharmacol Sci. 2012 May; 16 (5): 575-81.
> Colazingari S, Treglia M, Najjar R, Bevilacqua A. Daaweynta Kombiyuutarka ee Myoinositol Plus D-Chiro-Inositol, Lakin D-Chiro-Inositol, Miyuu Heli Karaa Hagaajinta Natiijooyinka IVF: Natiijooyinka ka soo baxa Maxkamad Kala Duwan. Arch Gynecol Obstet. 2013 Dec; 288 (6): 1405-11.